Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Shares Issued (2021 - 2024)

Opus Genetics (IRD) has disclosed Shares Issued for 8 consecutive years, with -$5.5 million as the latest value for Q4 2023.

  • On a quarterly basis, Shares Issued fell 223.13% to -$5.5 million in Q4 2023 year-over-year; TTM through Dec 2023 was $30000.0, a 99.32% decrease, with the full-year FY2023 number at $30000.0, down 99.32% from a year prior.
  • Shares Issued was -$5.5 million for Q4 2023 at Opus Genetics, down from $5.5 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $28.4 million in Q4 2021 to a low of -$5.5 million in Q4 2023.
  • A 3-year average of $5.5 million and a median of $2.3 million in 2021 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: tumbled 84.41% in 2022, then plummeted 223.13% in 2023.
  • Opus Genetics' Shares Issued stood at $28.4 million in 2021, then crashed by 84.41% to $4.4 million in 2022, then tumbled by 223.13% to -$5.5 million in 2023.
  • Per Business Quant, the three most recent readings for IRD's Shares Issued are -$5.5 million (Q4 2023), $5.5 million (Q3 2023), and $4.4 million (Q4 2022).